<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04070365</url>
  </required_header>
  <id_info>
    <org_study_id>AV2019</org_study_id>
    <nct_id>NCT04070365</nct_id>
  </id_info>
  <brief_title>FLEX Arteriovenous Access Registry</brief_title>
  <official_title>FLEX Arteriovenous Access Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VentureMed Group Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VentureMed Group Inc.</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluation of the FLEX Vessel Prep system combined with angioplasty in the treatment of&#xD;
      arteriovenous access stenosis.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">May 28, 2018</start_date>
  <completion_date type="Anticipated">August 2022</completion_date>
  <primary_completion_date type="Actual">June 9, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>Anatomic Success</measure>
    <time_frame>At the completion of the index procedure</time_frame>
    <description>Defined as the angiographic percentage of stenosis post procedure as &lt;30%</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Technical Success of the Device</measure>
    <time_frame>At the index procedure</time_frame>
    <description>Delivery to the target lesion, deployment of the treatment element, and retrieval</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Success</measure>
    <time_frame>6 Months</time_frame>
    <description>The resumption of normal dialysis for at least one session.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedural Success</measure>
    <time_frame>6 Months</time_frame>
    <description>Composite of anatomic and clinical success</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target Lesion Primary Patency</measure>
    <time_frame>6, 9 and 12 Months</time_frame>
    <description>The time interval of uninterrupted patency from initial study treatment to the next thrombosis or intervention performed on the target lesion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Circuit Primary Patency</measure>
    <time_frame>6, 9, and Months</time_frame>
    <description>The time interval from initial study treatment to the next access thrombosis or intervention performed within the vascular access circuit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assisted Primary Patency</measure>
    <time_frame>6, 9, and 12 Months</time_frame>
    <description>The time interval from initial study treatment to occlusion (thrombosis) of the vascular access circuit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Access Secondary Patency</measure>
    <time_frame>6, 9, and 12 Months</time_frame>
    <description>The time interval from initial study treatment to abandonment of the vascular access circuit.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">114</enrollment>
  <condition>Peripheral Artery Disease</condition>
  <condition>Arteriovenous Fistula Stenosis</condition>
  <condition>Arteriovenous Graft Stenosis</condition>
  <arm_group>
    <arm_group_label>FLEX Vessel Prep followed by angioplasty</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>FLEX Vessel Prep System followed by angioplasty</intervention_name>
    <description>Eligible Arteriovenous Fistula (AVF)/Arteriovenous Graft (AVG) will be treated with the FLEX Vessel Prep system followed by angioplasty.</description>
    <arm_group_label>FLEX Vessel Prep followed by angioplasty</arm_group_label>
    <other_name>Balloon Angioplasty</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with Arteriovenous Fistula or Arteriovenous Graft Stenosis, eligible for&#xD;
        FLEX/Angioplasty treatment.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Hemodialysis patient currently scheduled to undergo an intervention of their&#xD;
             arteriovenous fistula or graft due to clinical or hemodynamic abnormalities.&#xD;
&#xD;
          2. The patient is â‰¥18 years of age. Patient is legally competent, has been informed of&#xD;
             the study, voluntarily agrees to participate, and has signed the inform consent form.&#xD;
&#xD;
          3. The patient has a reasonable expectation of remaining on hemodialysis for 12 months.&#xD;
&#xD;
          4. The patient understands the study and is willing and able to comply with follow-up&#xD;
             requirements.&#xD;
&#xD;
          5. The patient is willing to provide informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. The patient has a known or suspected systemic infection.&#xD;
&#xD;
          2. The patient has a known or suspected infection of the hemodialysis graft.&#xD;
&#xD;
          3. The patient has an untreatable allergy to radiographic contrast material.&#xD;
&#xD;
          4. In the opinion of the operating physician, the patient's hemodialysis access is&#xD;
             unsuitable for endovascular treatment.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John Aruny, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dialysis Access Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Grandview Medical Center</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35243</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Flowers Hospital</name>
      <address>
        <city>Dothan</city>
        <state>Alabama</state>
        <zip>36305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Alabama</name>
      <address>
        <city>Tuscaloosa</city>
        <state>Alabama</state>
        <zip>35487</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Henry Ford Health System</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SSM Health SLU</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63117</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>FirstHealth Moore Regional Hospital</name>
      <address>
        <city>Pinehurst</city>
        <state>North Carolina</state>
        <zip>28374</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>JOBST Vascular Institute</name>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <zip>43606</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dialysis Access Institute</name>
      <address>
        <city>Orangeburg</city>
        <state>South Carolina</state>
        <zip>29118</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Richmond Vascular</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23235</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>August 23, 2019</study_first_submitted>
  <study_first_submitted_qc>August 23, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 28, 2019</study_first_posted>
  <last_update_submitted>July 26, 2021</last_update_submitted>
  <last_update_submitted_qc>July 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Arteriovenous Fistula</mesh_term>
    <mesh_term>Constriction, Pathologic</mesh_term>
    <mesh_term>Fistula</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

